Seelos TherapeuticsSEELQ
13F holders, Q1 2024 (March 31)36holders
$0.59avg. 13F price*
At the end of Q1 2024, 36 institutions reported holding Seelos Therapeutics Inc. (SEELQ) in their 13F filings. The largest holders were Wealth Effects LLC ($276K), AdvisorShares Investments LLC ($273K) and Gendell Jeffrey L ($254K).
- Company
- Seelos Therapeutics Inc.
- CUSIP
- 81577F208
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $37K |
| Exits | 8 | $534K |
Ownership 36 holders
| Wealth Effects LLC | 0.10% | Add +104.1% | 466,660 | $276K |
| AdvisorShares Investments LLC | 0.05% | Add +155.3% | 462,694 | $273K |
| Gendell Jeffrey L | 0.01% | Add +284.3% | 428,966 | $254K |
| Balyasny Asset Management L.P. | 0.00% | Add +43.2% | 379,239 | $224K |
| Vanguard Group Inc. | 0.00% | Reduce -1.1% | 280,866 | $166K |
| Modera Wealth Management, LLC | 0.00% | Add +126.0% | 157,617 | $93K |
| Morgan Stanley | 0.00% | Add +79.7% | 126,064 | $75K |
| Geode Capital Management, LLC | 0.00% | Add +249.0% | 102,408 | $61K |
| BlackRock Inc. | 0.00% | Reduce -0.0% | 55,961 | $33K |
| Strategic Family Wealth Counselors, L.L.C. | 0.01% | No change | 30,010 | $18K |
| Jane Street Group, LLC | 0.00% | New | 23,009 | $14K |
| XTX Topco Ltd | 0.00% | New | 16,071 | $9K |
| Two Sigma Investments, LP | 0.00% | Reduce -48.2% | 13,085 | $8K |
| State Street Corp. | 0.00% | No change | 12,948 | $8K |
| CRA Financial Services, LLC | 0.00% | New | 11,889 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +99.2% | 10,517 | $6K |
| UBS Group AG | 0.00% | Add +2397.8% | 10,166 | $6K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,018 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -5.9% | 8,233 | $5K |
| Carmichael Hill & Associates, Inc. | 0.00% | Add +60.0% | 8,000 | $5K |
| JPMorgan Chase & Co. | 0.00% | Add +100.1% | 4,032 | $2K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 3,757 | $2K |
| Group One Trading LLC | 0.00% | Reduce -79.9% | 1,824 | $1K |
| Vermillion & White Wealth Management Group, LLC | 0.00% | New | 996 | $588 |
| Crewe Advisors LLC | 0.00% | No change | 925 | $547 |
| Wells Fargo & Company | 0.00% | Add +18.6% | 440 | $260 |
| First Manhattan Co. Llc. | 0.00% | No change | 372 | $219 |
| NFSG Corp | 0.00% | No change | 199 | $118 |
| Hollencrest Capital Management | 0.00% | No change | 86 | $51 |
| Aspire Private Capital, LLC | 0.00% | No change | 50 | $30 |
| Westside Investment Management, Inc. | 0.00% | No change | 33 | $19 |
| Parallel Advisors, LLC | 0.00% | No change | 28 | $17 |
| National Bank of Canada | 0.00% | No change | 33 | $9 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 12 | $8 |
| BNP Paribas Financial Markets | 0.00% | New | 3 | $2 |
| Tsfg, LLC | 0.00% | No change | 3 | $0 |
"% of holder's portfolio" is SEELQ's weight in each manager's 13F, not the share of Seelos Therapeutics Inc. the manager owns.